Mason Street Advisors, LLC Glaukos Corp Transaction History

Mason Street Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $1.18 Million - $1.63 Million	-16,766 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $244 - $376	5 Added 0.03%	16,766 $1.26 Million
Q3 2020 Nov 13, 2020	BUY	$37.23 - $50.97 $67,609 - $92,561	1,816 Added 12.15%	16,761 $830,000
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $42,651 - $69,402	1,482 Added 11.01%	14,945 $574,000
Q1 2020 May 08, 2020	BUY	$25.53 - $70.14 $343,710 - $944,294	13,463 New	13,463 $415,000

307

46.8M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.